Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Seminars in Cardiovascular Medicine

The Journal of Lithuanian Heart Association

1 Issue per year

Open Access
Online
ISSN
1822-7767
See all formats and pricing
In This Section

Correlation of cardiac 123I-MIBG imaging with conventional markers of the heart failure

Donatas Vajauskas
  • Corresponding author
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
  • Centre of Radiology and Nuclear Medicine, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
  • Email:
/ Vytė Valerija Maneikienė
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
  • Centre of Cardiology and Angiology, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
/ Algirdas Edvardas Tamošiūnas
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
  • Centre of Radiology and Nuclear Medicine, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
/ Kęstutis Ručinskas
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
  • Centre of Cardiology and Angiology, Vilnius University Hospital Santariškių Klinikos, Vilnius, Lithuania
/ Raminta Lukšaitė
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
/ Evelina Balčiūnaitė
  • Vilnius University, Faculty of Medicine, Vilnius, Lithuania
Published Online: 2014-12-30 | DOI: https://doi.org/10.2478/semcard-2014-0002

Summary

Objectives: Quantitative values of cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) global and regional adrenergic innervation showed promising results in predicting clinical course of heart failure. Nevertheless data is lacking how global and regional cardiac 123I-MIBG imaging parameters correlate with patient’s clinical data and conventional heart failure markers.

Patients and methods: Eighty-six patientswith class II-IVNewYorkHeartAssociation (NYHA) heart failure were investigated. Patients underwent early and late cardiac 123I-MIBG planar and single photon emission computed tomography (SPECT) scanning. Global and regional cardiac 123I-MIBG scores were calculated and compared to conventional heart failure markers (left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP) and maximum rate of oxygen consumption (VO2 max)), followed by NYHA functional class clinical assessment at the time of investigation.

Results: Weak statistically significant correlation was noted between LVEF and global and regional cardiac adrenergic denervation scores, between BNP and VO2 max and global cardiac adrenergic denervation scores. Global and regional cardiac adrenergic denervation scores significantly differed within LVEF ranges. Global cardiac adrenergic denervation scores significantly differed within BNP levels and NYHA functional class.

Conclusions: Conventional cardiac heart failure markers had weak correlation with global and regional cardiac 123I-MIBG imaging parameters. Cardiac 123I-MIBG imaging markers differed significantly depending on LVEF and BNP levels, and NYHA functional class.

Keywords : 123I-MIBG; SPECT; heart failure; nuclear cardiology

References

  • [1] Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22-31.

  • [2] Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jaques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J NuclMed 1987;28:1620-4. [PubMed]

  • [3] Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med 1984;311:819-23. [Crossref]

  • [4] Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54. [Crossref]

  • [5] Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535-46.

  • [6] Jacobson AF, Senior R, Cerqueira MD,Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.

  • [7] Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiacmetaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7. [PubMed]

  • [8] Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois- Randé JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J NuclMed 1999;40:917-23. [PubMed]

  • [9] Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.

  • [10] Paul M,Wichter T, Kies P, Gerss J,Wollmann C, Rahbar K, et al. Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias. J NuclMed 2011;52:1-7.

  • [11] Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535-46.

  • [12] Arimoto T, Takeishi Y, Niizeki T, Koyama Y, Okuyama H, Nozaki N, et al. Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure. Ann Nucl Med 2005;19:535-40. [PubMed] [Crossref]

  • [13] Fujimoto S, Amano H, Inoue A, Ishida S, Yamashina S, Yamashina H, et al. Usefulness of 123Imetaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function. Ann Nucl Med 2004;18:591-8.

  • [14] Katoh S, Shishido T, Kutsuzawa D, Arimoto T, Netsu S, Funayama A, et al. Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction. Ann Nucl Med 2010;24:679-86. [Web of Science]

  • [15] Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J NuclMedMol Imaging 2010;37:1802-12. [Web of Science]

  • [16] Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623-32.

  • [17] Germano G, Kavanagh PB, Chen J, Waechter P, Su HT, Kiat H, et al. Operator-less processing of myocardial perfusion SPECT studies. J NuclMed 1995;36:2127-32.

  • [18] Bax JJ, Boogers M, Henneman MM. Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? Eur J Nucl Med Mol Imaging 2008;35:532-4. [Web of Science] [PubMed]

  • [19] Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J 2006;70:703-9. [Crossref] [PubMed]

About the article

Received: 2014-05-05

Accepted: 2014-07-01

Published Online: 2014-12-30

Published in Print: 2014-12-01



Citation Information: Seminars in Cardiovascular Medicine, ISSN (Online) 1822-7767, DOI: https://doi.org/10.2478/semcard-2014-0002. Export Citation

© by Donatas Vajauskas. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Comments (0)

Please log in or register to comment.
Log in